PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in PolyPid Ltd. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +2 vs. Q1 2021
- Shares held
- 1.64M
- +39.4K (+2.5%) vs. Q1 2021
- Total value
- $14.9M
- +$190.2K (+1.3%) vs. Q1 2021
- New holders
- 5
- 8 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYPD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $16.7M |
| Q1 2026 | 19 | $13.7M |
| Q4 2025 | 19 | $13.0M |
| Q3 2025 | 16 | $9.45M |
| Q2 2025 | 15 | $10.2M |
| Q1 2025 | 13 | $6.90M |
| Q4 2024 | 14 | $7.50M |
| Q3 2024 | 12 | $6.64M |
| Q2 2024 | 9 | $5.18M |
| Q1 2024 | 8 | $5.13M |
| Q4 2023 | 5 | $79.6K |
| Q3 2023 | 4 | $93.2K |
| Q2 2023 | 14 | $155.2K |
| Q1 2023 | 11 | $147.8K |
| Q4 2022 | 13 | $265.3K |
| Q3 2022 | 18 | $566.0K |
| Q2 2022 | 27 | $4.95M |
| Q1 2022 | 27 | $6.10M |
| Q4 2021 | 27 | $8.71M |
| Q3 2021 | 19 | $11.9M |
| Q2 2021 | 22 | $14.9M |
| Q1 2021 | 20 | $14.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding PolyPid Ltd.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 327 | $3.00K | 0.00% | −2,021−86.1% | Reduced |
| Steward Partners Investment Advisory, LLC | 1,615 | $15.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 2,053 | $19.0K | 0.00% | +1,953+1,953.0% | Added |
| BlackRock Inc. | 3,091 | $28.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,494 | $32.0K | 0.00% | +3,494 | New |
| Geode Capital Management, LLC | 11,181 | $101.0K | 0.00% | +11,181 | New |
| 1623 Capital LLC | 11,627 | $105.0K | 0.04% | +2,608+28.9% | Added |
| Cresset Asset Management, LLC | 11,719 | $106.0K | 0.00% | +11,719 | New |
| Meitav Dash Investments Ltd | 14,500 | $131.0K | 0.00% | +14,500 | New |
| Raymond James & Associates | 15,945 | $144.0K | 0.00% | +1,566+10.9% | Added |
| Federated Hermes, Inc. | 18,194 | $165.0K | 0.00% | −12,130−40.0% | Reduced |
| Renaissance Technologies LLC | 19,189 | $174.0K | 0.00% | +19,189 | New |
| Raymond James Financial Services Advisors, Inc. | 19,816 | $179.0K | 0.00% | +3,160+19.0% | Added |
| JPMorgan Chase & Co | 20,830 | $189.0K | 0.00% | −790−3.7% | Reduced |
| Invesco Ltd. | 24,119 | $218.0K | 0.00% | −60,462−71.5% | Reduced |
| Millennium Management LLC | 56,530 | $512.0K | 0.00% | +34,227+153.5% | Added |
| Alliancebernstein L.P. | 100,000 | $906.0K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 111,617 | $1.01M | 0.00% | −5,586−4.8% | Reduced |
| UBS Group AG | 154,160 | $1.40M | 0.00% | +2,677+1.8% | Added |
| Silverarc Capital Management, LLC | 154,566 | $1.40M | 0.74% | +4,740+3.2% | Added |
| Moore Capital Management, LP | 281,977 | $2.55M | 0.05% | −1,446−0.5% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 605,382 | $5.48M | 0.01% | +27,635+4.8% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,039−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,250−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |